Understanding, Diagnosing, and Treating Neurotrophic Keratit -

Name: Understanding, Diagnosing, and Treating Neurotrophic Keratitis: An Overview
Uploaded: 2019-12-11T10:00:00+00:00
Duration: 1 h 4 min 22 s
Description: This certified continuing medical education activity is designed for anterior segment specialists, general ophthalmologists, and optometrists involved in t

Overview
This certified continuing medical education activity is designed for anterior segment specialists, general ophthalmologists, and optometrists involved in the management of corneal disorders.Supported through an educational grant from Dompé.
Learning Objectives
At the completion of this educational activity, the participating ophthalmologist will be better able to:
- Describe the stages of neurotrophic keratitis, and how to differentiate it from similar diseases.
- Recognize the various potential causes of neurotrophic keratitis.
- Understand mechanisms of action of newer treatments and when they should be introduced into treatment regimens for neurotrophic keratitis.
- Identify the relationships between disease characteristics, drug, treatment frequency, visual, and anatomic outcomes.
Accreditation
Accreditation Statement Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Statement Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Grantor Statement Supported through an educational grant from Dompé.
Faculty and Disclosures
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
DISCLOSURE POLICY It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity. FacultyTerry Kim, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Alcon, Allergan, Avedro, Avellino Labs, Bausch + Lomb, Blephex, CorneaGen, Dompé, Eyenovia, Johnson & Johnson Vision, Kala Pharmaceuticals, Novabay Pharmaceuticals, Novartis, Ocular Therapeutix, Omeros, Presbyopia Therapies, Shire, Sight Sciences, Simple Contacts, Surface, and Zeiss. Francis S. Mah, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Dompé. Editorial SupportErin K. Fletcher, MIT, director of compliance and education, Evolve, has no financial relationships with commercial interests. Susan Gallagher-Pecha, director of client services and project management, Evolve, has no financial relationships with commercial interests. Cassandra Richards, director of education development, Evolve, has no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 12/11/2019
Expiration Date: 12/31/2020